• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探究左心室辅助装置驱动线感染的潜在术前风险因素。

Investigating Potential Preoperative Risk Factors for Left Ventricular Assist Device Driveline Infections.

作者信息

Madden Alexandra, Moser Melanie, Eisen Howard

机构信息

Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Curr Cardiol Rep. 2025 Jul 22;27(1):117. doi: 10.1007/s11886-025-02267-y.

DOI:10.1007/s11886-025-02267-y
PMID:40694154
Abstract

PURPOSE OF REVIEW

To identify potential preoperative risk factors that predispose a patient to developing a left ventricular assist device driveline infection.

RECENT FINDINGS

The fully magnetically-levitated left ventricular assist device has proven to be a safe and effective durable option for patients with advanced heart failure. However, driveline infections are a significant adverse event that impact patient mortality, morbidity, and quality of life. Potential preoperative risk factors such as INTERMACS score, temporary cardiovascular support, body mass index, hemoglobin A1C, prealbumin, infection, and hospital length of stay do not appear to significantly predispose a patient to developing a left ventricular assist device driveline infection. There is a need for more extensive research on postoperative patient and driveline management in order to identify high risk patients and delineate best practice to decrease the risk and burden of driveline infections.

摘要

综述目的

确定使患者易发生左心室辅助装置驱动线感染的潜在术前危险因素。

最新发现

全磁悬浮左心室辅助装置已被证明是晚期心力衰竭患者安全有效的长期治疗选择。然而,驱动线感染是一种严重的不良事件,会影响患者的死亡率、发病率和生活质量。INTERMACS评分、临时心血管支持、体重指数、糖化血红蛋白、前白蛋白、感染和住院时间等潜在术前危险因素似乎并未显著使患者易发生左心室辅助装置驱动线感染。需要对术后患者和驱动线管理进行更广泛的研究,以识别高危患者并确定最佳实践,以降低驱动线感染的风险和负担。

相似文献

1
Investigating Potential Preoperative Risk Factors for Left Ventricular Assist Device Driveline Infections.探究左心室辅助装置驱动线感染的潜在术前风险因素。
Curr Cardiol Rep. 2025 Jul 22;27(1):117. doi: 10.1007/s11886-025-02267-y.
2
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.左心室辅助装置作为晚期心力衰竭的终末期治疗的临床和成本效益:系统评价和经济评估。
Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009.
3
Is There an Association Between Living in a Rural Area and the Incidence of Postoperative Complications or Hospital Readmissions Following Left Ventricular Assist Device (LVAD) Implantation, Compared to Urban Lvad Recipients? A Systematic Review.与城市左心室辅助装置(LVAD)接受者相比,农村地区居民在LVAD植入术后的并发症发生率或再次入院率之间是否存在关联?一项系统评价。
Clin Cardiol. 2025 Jan;48(1):e70068. doi: 10.1002/clc.70068.
4
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
5
Vitamin D Deficiency and Driveline Infections in Patients With Left Ventricular Assist Devices.左心室辅助装置患者的维生素D缺乏与导管相关感染
Artif Organs. 2025 Jul;49(7):1185-1191. doi: 10.1111/aor.14988. Epub 2025 Mar 17.
6
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.第二代和第三代左心室辅助装置作为适合心脏移植的成人移植桥接或替代治疗的临床效果和成本效益:系统评价和成本效益模型。
Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530.
7
Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation.作为耐用辅助装置植入桥梁的各种微轴流泵装置的多中心比较。
ESC Heart Fail. 2025 Aug;12(4):2552-2564. doi: 10.1002/ehf2.15282. Epub 2025 Apr 4.
8
Driveline Relocation and Vacuum-Assisted Closure for Ventricular Assist Device Driveline Infections.心室辅助装置驱动线感染的驱动线重新定位及负压封闭引流术
J Cardiovasc Dev Dis. 2025 Jun 3;12(6):211. doi: 10.3390/jcdd12060211.
9
Systemic Inflammatory Response Syndrome全身炎症反应综合征
10
Evaluation of the ventricular assist device programme in the UK.英国心室辅助装置项目评估
Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480.

本文引用的文献

1
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.全磁悬浮离心式左心室辅助装置与长期预后:ELEVATE 注册研究。
Eur Heart J. 2024 Feb 21;45(8):613-625. doi: 10.1093/eurheartj/ehad658.
2
The Society of Thoracic Surgeons Intermacs 2023 Annual Report: Focus on Magnetically Levitated Devices.胸外科医师学会 Intermacs 2023 年度报告:重点关注磁悬浮设备。
Ann Thorac Surg. 2024 Jan;117(1):33-44. doi: 10.1016/j.athoracsur.2023.11.004. Epub 2023 Nov 8.
3
Preventing driveline infection during left ventricular assist device support by the HeartMate 3: A survey-based study.
通过 HeartMate 3 预防左心室辅助装置支持期间的传动系统感染:一项基于调查的研究。
Artif Organs. 2022 Jul;46(7):1409-1414. doi: 10.1111/aor.14187. Epub 2022 Feb 3.
4
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Nutritional Assessment.美国神经外科医师协会系统评价与循证指南:围手术期脊柱:术前营养评估。
Neurosurgery. 2021 Oct 13;89(Suppl 1):S26-S32. doi: 10.1093/neuros/nyab318.
5
Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes.术前感染、鼻腔金黄色葡萄球菌定植和肠道微生物群与左心室辅助装置结局的关系。
Eur J Heart Fail. 2021 Aug;23(8):1404-1415. doi: 10.1002/ejhf.2215. Epub 2021 May 31.
6
Outcomes of left ventricular assist device implantation for advanced heart failure in critically ill patients (INTERMACS 1 and 2): A retrospective study.严重心力衰竭患者应用左心室辅助装置治疗的结局(INTERMACS 1 和 2):一项回顾性研究。
Artif Organs. 2021 Jul;45(7):706-716. doi: 10.1111/aor.13897. Epub 2021 Feb 1.